DA
DCF Advisers Portfolio holdings
AUM
$208M
1-Year Return
21.52%
This Quarter Return
+10.62%
1 Year Return
+21.52%
3 Year Return
+75.42%
5 Year Return
+129.34%
10 Year Return
–
AUM
$199M
AUM Growth
+$14.8M
(+8.1%)
Cap. Flow
-$3.11M
Cap. Flow
% of AUM
-1.56%
Top 10 Holdings %
Top 10 Hldgs %
53.98%
Holding
81
New
1
Increased
18
Reduced
14
Closed
8
Top Buys
| 1 |
AbbVie
ABBV
|
$2.92M |
| 2 |
Intel
INTC
|
$1.03M |
| 3 |
IMPL
Impel Pharmaceuticals Inc. Common Stock
IMPL
|
$915K |
| 4 |
AT&T
T
|
$800K |
| 5 |
Regeneron Pharmaceuticals
REGN
|
$758K |
Top Sells
| 1 |
Verizon
VZ
|
$2.6M |
| 2 |
Alibaba
BABA
|
$2.15M |
| 3 |
VanEck Gold Miners ETF
GDX
|
$1.92M |
| 4 |
Advanced Micro Devices
AMD
|
$1.44M |
| 5 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$1.05M |
Sector Composition
| 1 | Healthcare | 49.6% |
| 2 | Technology | 16.99% |
| 3 | Communication Services | 8.96% |
| 4 | Financials | 5.94% |
| 5 | Consumer Discretionary | 4.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Altimmune
ALT
$314M
| $2.57M | 1.04% |
280,700
+41,500
| +17% | +$380K |
|
27
VanEck Junior Gold Miners ETF
GDXJ
$6.82B
| $2.31M | 0.94% |
55,000
+15,000
| +38% | +$629K |
|
|
28
AT&T
T
$211B
| $2.28M | 0.92% |
122,470
+43,030
| +54% | +$800K |
|
29
Apple
AAPL
$3.52T
| $2.22M | 0.9% |
12,500
| – | – |
|
|
IMPL
30
DELISTED
Impel Pharmaceuticals Inc. Common Stock
IMPL
| $2.21M | 0.9% |
256,027
+106,027
| +71% | +$915K |
|
|
SGEN
31
DELISTED
Seagen Inc. Common Stock
SGEN
| $2.09M | 0.85% |
13,500
| – | – |
|
32
Bristol-Myers Squibb
BMY
$94.3B
| $2.03M | 0.82% |
32,500
| – | – |
|
33
LENSAR
LNSR
$144M
| $1.68M | 0.68% |
279,788
| – | – |
|
34
Marvell Technology
MRVL
$55.3B
| $1.53M | 0.62% |
17,500
| – | – |
|
35
iShares Silver Trust
SLV
$20B
| $1.45M | 0.59% |
67,500
-12,500
| -16% | -$269K |
|
36
Qualcomm
QCOM
$171B
| $1.37M | 0.56% |
7,500
| – | – |
|
|
AERI
37
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $1.35M | 0.55% |
192,065
+55,564
| +41% | +$390K |
|
38
Morgan Stanley
MS
$239B
| $1.23M | 0.5% |
12,500
| – | – |
|
|
STEW
39
SRH Total Return Fund
STEW
$1.79B
| $1.18M | 0.48% |
83,000
| – | – |
|
|
40
Intel
INTC
$106B
| $1.03M | 0.42% |
+20,000
| New | +$1.03M |
|
41
Nokia
NOK
$24.4B
| $933K | 0.38% |
150,000
| – | – |
|
42
Illinois Tool Works
ITW
$76.8B
| $864K | 0.35% |
3,500
| – | – |
|
43
Microsoft
MSFT
$3.77T
| $841K | 0.34% |
2,500
| – | – |
|
44
Vir Biotechnology
VIR
$700M
| $837K | 0.34% |
20,000
-8,000
| -29% | -$335K |
|
45
NXP Semiconductors
NXPI
$56.3B
| $797K | 0.32% |
3,500
| – | – |
|
46
Energy Transfer Partners
ET
$60.4B
| $774K | 0.31% |
94,000
+72,500
| +337% | +$597K |
|
47
AstraZeneca
AZN
$253B
| $742K | 0.3% |
12,745
| – | – |
|
48
Equillium
EQ
$61.1M
| $708K | 0.29% |
187,666
+2,000
| +1% | +$7.55K |
|
|
AMRN
49
Amarin Corp
AMRN
$306M
| $539K | 0.22% |
8,000
| – | – |
|
50
Becton Dickinson
BDX
$54.6B
| $503K | 0.2% |
2,050
-1,025
| -33% | -$252K |
|